Role of platelet-activating factor in acid-induced esophageal mucosal injury

Digestive Diseases and Sciences

Volumn 52, Issue 8, 2007, Pages 1861-1866

  Paterson, W G ^a   Kieffer, C A ^a   Feldman, M J ^a   Miller, D V ^a   Morris, G P ^a  

^a HOTEL DIEU HOSPITAL   (Canada)

Author keywords

Esophagitis; Gastroesophageal reflux disease; Mast cells; Reflux

Indexed keywords

3 BROMO 5 [N PHENYL N [2 [[2 (1,2,3,4 TETRAHYDRO 2 ISOQUINOLYLCARBONYLOXY)ETHYL]CARBAMOYL]ETHYL]CARBAMOYL] 1 PROPYLPYRIDINIUM NITRATE; ACID; CROMOGLYCATE DISODIUM; DOXANTRAZOLE; HYDROCHLORIC ACID; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ESOPHAGEAL MUCOSAL INJURY; ESOPHAGUS INJURY; FEMALE; HISTOLOGY; MALE; MAST CELL; NONHUMAN; OPOSSUM; PRIORITY JOURNAL; SCORING SYSTEM;

ANIMALS; CROMOLYN SODIUM; ESOPHAGITIS, PEPTIC; GASTROESOPHAGEAL REFLUX; MAST CELLS; OPOSSUMS; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION INHIBITORS; PYRIDINIUM COMPOUNDS; TETRAHYDROISOQUINOLINES; THIOXANTHENES; XANTHONES;

EID: 34347405752     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9385-9     Document Type: Article

References (29)

1. Orlando RC (2000) Mechanisms of reflux-induced epithelial injuries in the esophagus. Am J Med 108(4A):104S-108S
2. Ying LTJ, Hurlbut DJ, Paterson WG (1996) Human mucosal mast cell number and relationship to vasculature in acid-induced inflammatory conditions of the esophagus. Can J Gastroenterol 10 (Suppl A):51A
3. Barclay RL, Dinda PK, Morris GP, Paterson WG (1995) Morphological evidence of mast cell degranulation in an animal model of acid-induced esophageal mucosal injury. Dig Dis Sci 40:1651-1658
4. Feldman MJ, Morris GP, Dinda PK, Paterson WG (1996) Mast cells mediate acid-induced augmentation of opossum esophageal blood flow via histamine and nitric oxide. Gastroenterology 110:121-128
5. Paterson WG (1998) Role of mast cell-derived mediators in acid-induced shortening of the esophagus. Am J Physiol 274 (Gastrointest Liver Physiol 37):G385-G388
6. Paterson WG, Kolyn DM (1994) Esophageal shortening induced by acute intraluminal acid perfusion: a cause for hiatus hernia? Gastroenterology 107:1736-1740
7. White RJ, Zhang Y, Morris GP, Paterson WG (2001) Esophagitis-related esophageal shortening in opossum is associated with longitudinal muscle hyperresponsiveness. Am J Physiol 280:G463-G469
8. Zhang X, Geboes K, Depoortere I, Tack J, Janssens J, Sifrim D (2005) Effect of repeated cycles of acute esophagitis and healing on esophageal peristalsis, tone, and length. Am J Physiol (Gastrointest Liver Physiol) 288(6):G1339-1346
9. Dunne DP, Paterson WG (2000) Acid-induced oesophageal shortening in humans: a cause for hiatus hernia? Can J Gastroenterol 14:847-850
10. Izuoka T, Takayama Y, Sugiura T, Taniguchi H, Tamura T, Kitashiro S, Jikuhara T, Iwasaka T (1998) Role of platelet-activating factor on extravascular lung water after coronary reperfusion in dogs. Jpn J Physiol 48(2):157-161
11. Yamaguchi Y, Matsumura F, Liang J, Okabe K, Matsuda T, Ohshiro H, Ishihara K, Akizuki E, Yamada S, Ogawa M (1999) Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats. Pancreas 18(4):355-363
12. Poeze M, Froon AH, Ramsay G, Buurman WA, Greve JW (2000) Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group. Shock 14(4):421-428
13. Zijlstra FK, Hynna-Liepert TT, Dinda PK, Beck IT, Paterson WG (1991) Microvascular permeability increases early in the course of acid-induced esophageal injury. Gastroenterology 101:295-302
14. Cheng L, Cao W, Fiocchi C, Behar J, Biancani P, Harnett KM (2005) Platelet-activating factor and prostaglandin E2 impair esophageal Ach release in experimental esophagitis. Am J Physiol Gastrointest Liver Physiol 289(3):G418-G428
15. Tobey NA, Carson JL, Alkiek RA, Orlando RC (1996) Dilated intercellular spaces: a morphological feature of acid-reflux damaged human esophageal epithelium. Gastroeneterology 111:1200-1205
16. Morgan GP, Williams JG (1994) Inflammatory mediators in the oesophagus. Gut 35:297-298
17. Northway MG, Libshitz HI, Osborne BM, Feldman MS, Mamel JJ, West JH, Szwarc IA (1980) Radiation esophagitis in the opossum: radioprotection with indomethacin. Gastroenterology 78:883-892
18. Harmon JW, Johnson LF, Maydonovitch CL (1980) Effects of 16, 16-dimethyl PGE2 on bile-induced increases in H+ permeability of rabbit esophagus. Adv Prostagland Thrombox Res 8:1577-1579
19. Eastwood GL, Beck BD, Castell DO, Brown FC, Fletcher JR (1981) Beneficial effect of indomethacin on acid-induced esophagitis in cats. Dig Dis Sci 26:601-608
20. Ottignon Y, Alber D, Moussard C, Deschamps JP, Carayon P, Henry JC (1987) Esophageal mucosal prostaglandin E2 levels in health and in gastroesophageal reflux disease. Prostagland Leukotrienes Med 29:141-151
21. Stein BE, Schwartzman ML, Carroll MA (1989) Role of arachidonic acid metabolites in acid-peptic injury to rabbit esophagus. Gastroenterology 97:278-283
22. Lanas A, Jimenez P, Ferrandez A, Escartin A, Arenas J, Esteva F, Ortego J (2003) Selective COX-2 inhibition is associated with decreased mucosal damage induced by acid and pepsin in rabbit esophagitis. Inflammation 27(1):21-29
23. Opal S, Laterre PF, Abraham E, Francois B, Wittebole X, Lowry S, Dhainaut JF, Warren B, Dugernier T, Lopez A, Sanchez M, Demeyer I, Jauregui L, Lorente JA, McGee W, Reinhart K, Kljucar S, Souza S, Pribble J, Controlled Mortality Trial of Platelet-Activating Factor Acetylhydrolase in Severe Sepsis Investigators (2004) Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial. Crit Care Med 32:332-341
24. Imrie WE, McKay CJ (1999) The possible role of platelet-activating factor antagonist therapy in the management of severe acute pancreatitis. Baillieres Best Pract Res Clin Gastroenterol 13(2):357-364
25. Ewer AK (2002) Role of platelet-activating factor in the pathophysiology of necrotizing enterocolitis. Acta Paediatr Suppl 91(437):2-5
26. Kubes P, Ibbotson G, Russell J, Wallace JL, Granger DN (1990) Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. Am J Physiol 259(2; Pt 1):G300-G305
27. Wallace JL, Hogaboam CM, McKnight GW (1990) Platelet-activating factor mediates gastric damage induced by hemorrhagic shock. Am J Physiol 259(1; Pt 1):G140-G146
28. Konturek SJ, Brzozowksi T (1991) Role of leukotrienes and platelet-activating factor in gastric mucosal damage repair. J Physiol Pharmacol 42(2):107-133
29. Cheng L, Cao W, Fiocchi C, Behar J, Biancani P, Harnett KM (2006) HCl-induced inflammatory mediators in cat esophageal mucosa and inflammatory mediators in esophageal circular muscle in an in vitro model of esophagitis. Am J Physiol (Gastrointest Liver Physiol), 290(6):G1307-G1317